Clinical trial
Combination Chemotherapy Following Surgery in Treating Patients With Advanced…
NCT00003133 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003133 |
|---|---|
| Title | Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer |
| Official title | Sequential Gemcitabine, Doxorubicin, Then Paclitaxel Plus Cisplatin Adjuvant Chemotherapy After Complete Resection of Locally Advanced Transitional Cell Carcinoma of the Urothelium |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cisplatin, doxorubicin hydrochloride, gemcitabine hydrochloride, paclitaxel |
| Enrollment | 30 |
| Start date | Sep 1, 1997 |
| Primary completion | Jan 1, 2003 |
| Completion | Jan 1, 2003 |
| First posted | Apr 30, 2004 |
| Last update posted | Jun 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: